Overview
Jesko Momotow practices practicing medicine in Koeln, Germany.
Momotow is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Classical Hodgkin Lymphoma, Hodgkin Lymphoma, and Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).
They are actively involved in clinical research, co-authoring 9 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jesko Momotow
Is Jesko Momotow a top-rated expert for Classical Hodgkin Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Jesko Momotow is classified as an Distinguished expert for Classical Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jesko Momotow participate in research or clinical trials?
Yes. Jesko Momotow has published 9 articles and abstracts on conditions like Classical Hodgkin Lymphoma. You can view a list of Jesko Momotow's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Classical Hodgkin LymphomaMomotow isDistinguished. Learn about Classical Hodgkin Lymphoma.
- Hodgkin LymphomaMomotow isDistinguished. Learn about Hodgkin Lymphoma.
- Experienced
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)